UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 672

Sortiert nach

Genetic Susceptibility to Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (7), p.2025-2030

2013

Link zum Volltext

Verfügbarkeit prüfen

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer

JAMA : the journal of the American Medical Association, 2018-06, Vol.319 (23), p.2401

2018

Link zum Volltext

Verfügbarkeit prüfen

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer

Journal of clinical oncology, 2015-02, Vol.33 (4), p.304-311

2015

Link zum Volltext

Verfügbarkeit prüfen

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma

Human pathology, 2014-08, Vol.45 (8), p.1630-1638

2014

Link zum Volltext

Verfügbarkeit prüfen

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort

JNCI : Journal of the National Cancer Institute, 2020-12, Vol.112 (12), p.1231-1241

2020

Link zum Volltext

Verfügbarkeit prüfen

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

JAMA oncology, 2017-09, Vol.3 (9), p.1190

2017

Link zum Volltext

Verfügbarkeit prüfen

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls

Gynecologic oncology, 2017-11, Vol.147 (2), p.375-380

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

American journal of human genetics, 2016-05, Vol.98 (5), p.801-817

2016

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework

Genome medicine, 2019-12, Vol.12 (1), p.3-3, Article 3

2019

Link zum Volltext

Verfügbarkeit prüfen

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

Breast cancer research and treatment, 2017-02, Vol.161 (3), p.575-586

2017

Link zum Volltext

Verfügbarkeit prüfen

BRCA2 Localization to the Midbody by Filamin A Regulates CEP55 Signaling and Completion of Cytokinesis

Developmental cell, 2012-07, Vol.23 (1), p.137-152

2012

Link zum Volltext

Verfügbarkeit prüfen

Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers

Nature, 2008-02, Vol.451 (7182), p.1116-1120

2008

Link zum Volltext

Verfügbarkeit prüfen

The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers

JNCI : Journal of the National Cancer Institute, 2018-09, Vol.110 (9), p.1030-1034

2018

Link zum Volltext

Verfügbarkeit prüfen

Tex14, a Plk1-Regulated Protein, Is Required for Kinetochore-Microtubule Attachment and Regulation of the Spindle Assembly Checkpoint

Molecular cell, 2012-03, Vol.45 (5), p.680-695

2012

Link zum Volltext

Verfügbarkeit prüfen

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (42), p.15172-15177

2014

Link zum Volltext

Verfügbarkeit prüfen

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

Nature communications, 2022-01, Vol.13 (1), p.514-514, Article 514

2022

Link zum Volltext

Verfügbarkeit prüfen

Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2

Molecular cell, 2006-06, Vol.22 (6), p.719-729

2006

Link zum Volltext

Verfügbarkeit prüfen

A contemporary review of male breast cancer: current evidence and unanswered questions

Cancer and metastasis reviews, 2018-12, Vol.37 (4), p.599-614

2018

Link zum Volltext

Verfügbarkeit prüfen

The contributions of breast density and common genetic variation to breast cancer risk

JNCI : Journal of the National Cancer Institute, 2015-05, Vol.107 (5), p.1

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches

American journal of human genetics, 2018-02, Vol.102 (2), p.233-248

2018

Link zum Volltext

Verfügbarkeit prüfen

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer

PloS one, 2022-12, Vol.17 (12), p.e0278408-e0278408

2022

Link zum Volltext

Verfügbarkeit prüfen

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance

American journal of human genetics, 2021-03, Vol.108 (3), p.458-468

2021

Link zum Volltext

Verfügbarkeit prüfen

Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4082-4088

2009

Link zum Volltext

Verfügbarkeit prüfen

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)

Human mutation, 2012-01, Vol.33 (1), p.8-21

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 672

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(661)
Mit Volltextzugriff
(637)

Publikationsform

Artikel
(670)
Buchkapitel
(2)

Sprache

Englisch
(670)
Japanisch
(129)
Norwegisch
(18)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Genetic Susceptibility to Triple-Negative Breast Cancer

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients

BRCA2 Localization to the Midbody by Filamin A Regulates CEP55 Signaling and Completion of Cytokinesis

Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers

The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers

Tex14, a Plk1-Regulated Protein, Is Required for Kinetochore-Microtubule Attachment and Regulation of the Spindle Assembly Checkpoint

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2

A contemporary review of male breast cancer: current evidence and unanswered questions

The contributions of breast density and common genetic variation to breast cancer risk

Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance

Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)

Suchergebnisse filtern